|
 |
| On the cover: The pace of science and technology is accelerating, and the future is arriving much faster. During the great process of reaching the future, the now highly comprehensive and interdisciplinary network of science, so-called 'ScienceX' by The Innovation, plays a more important role than ever before. We believe the development of interdisciplinary science and technology concerns our destiny in the coming future. |
|
|
| Add comment (English only) |
|
|
|
|
|
| Position: Home > issue > May 10, 2022 Volume 3, Issue 4 |
|
|
|
| Toripalimab in advanced biliary tract cancer |
Category: Report Download:  PDF  Figure  Endnote |
| Author: Wei Li, Yueqi Wang, Yiyi Yu, Qian Li, Yan Wang, Chenlu Zhang, Xiaojing Xu, Xi Guo, Yu Dong, Yuehong Cui, Qing Hao, Lujia Huang, Houbao Liu, Tianshu Liu |
|
|
GRAPHICAL ABSTRACT
Gemcitabine combined with platinum/fluorouracil drugs is the standard first-line treatment for advanced biliary tract cancers (BTCs). This study explored the safety and efficacy of Toripalimab plus gemcitabine and S-1 (GS) as the first-line treatment for advanced BTCs. At a one-sided significance level of 0.025, a total of 50 patients could provide 80% power to show the efficacy at targeted progression free survival rate at 6 months of 70% versus 40% for the combined treatment. This single-arm, phase II study enrolled 50 patients with advanced BTCs who previously received no systemic treatment.
|
|
|
|
TheInnovation´´ÐÂ
TheInnovation´´ÐÂ
The_Innovation
office@the-innovation.org
Official£º